13 Contraception for women with diabetes: An update

Baillière's Clinical Obstetrics and Gynaecology - Tập 5 - Trang 493-503 - 1991
S.O. Skouby, L. Mølsted-Pedersen, K.R. Petersen

Tài liệu tham khảo

Beck, 1969, Comparison of the mechanisms underlying carbohydrate intolerance in subclinical diabetic women during pregnancy and during post-partum oral contraceptive steroid treatment, Journal of Clinical Endocrinology and Metabolism, 29, 807, 10.1210/jcem-29-6-807 De Pirro, 1978, Insulin receptors during the menstrual cycle in normal women, Journal of Clinical Endocrinology and Metabolism, 47, 1387, 10.1210/jcem-47-6-1387 Djursing, 1982, Clinical and hormonal characteristics in women with anovulation and insulin treated diabetes mellitus, American Journal of Obstetrics and Gynecology, 143, 867, 10.1016/0002-9378(82)90466-5 Fotherby, 1990, Potency and pharmacokinetics of gestagens, Contraception, 41, 533, 10.1016/0010-7824(90)90062-Z Gaspard, 1990, Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism and the development of cardiovascular disease, American Journal of Obstetrics and Gynecology, 163, 334, 10.1016/0002-9378(90)90578-U Godsland, 1990, Low-dose oral contraceptives and carbohydrate metabolism, American Journal of Obstetrics and Gynecology, 163, 348, 10.1016/0002-9378(90)90580-Z Gosden, 1982, Intrauterine devices in diabetic women, Lancet, i, 530, 10.1016/S0140-6736(82)92044-X Kalkhoff, 1975, Effects of oral contraceptive agents on carbohydrate metabolism, Journal of Steroid Biochemistry, 6, 949, 10.1016/0022-4731(75)90333-7 Larsson, 1977, Fibrinolytic activity of the endometrium in diabetic women using Cu-IUDs, Contraception, 15, 711, 10.1016/S0010-7824(77)80008-5 Larsson-Cohn, 1977, Metabolic and hormonal effect of post menopausal estrogen replacement treatment. Glucose, insulin and human growth hormone levels during oral glucose tolerance tests, Acta Endocrinologica, 86, 583, 10.1530/acta.0.0860583 Lebech, 1977, Oral contraception with natural human oestrogen—differences between natural and artificial oestrogens, 33 Leslie, 1987, Haemoglobin A1C in diabetic pregnancy, Lancet, ii, 958 Liedholm, 1975, Fibrinolytic activity of the rat ovum, appearance during tubal passage and disappearance at implantation, International Journal of Fertility, 20, 24 Mishell, 1989, Contraception, New England Journal of Medicine, 20, 777, 10.1056/NEJM198903233201206 Orme, 1983, Clinical pharmacokinetics of oral contraceptive steroids, Clinical Pharmacokinetics, 8, 95, 10.2165/00003088-198308020-00001 Osler, 1974, Contraception in diabetic women, Acta Endocrinologica, 182, 87 Pedersen, 1979, Congenital malformations: the possible role of diabetes care outside pregnancy, 63, 265 Rådberg, 1981, Oral contraception in diabetic women. Diabetes control, serum and high density lipoprotein lipids during low dose progestogen, combined estrogen/progestogen and non-hormonal contraception, Acta Endocrinologica, 98, 246, 10.1530/acta.0.0980246 Runnebaum, 1987, New progestogens in oral contraceptives, American Journal of Obstetrics and Gynecology, 157, 1059, 10.1016/S0002-9378(87)80132-1 Samsioe, 1983, Oral contraception with a nonalkylated estrogen component: effects on lipid metabolism, Gynecologic and Obstetric Investigation, 15, 275, 10.1159/000299421 Skouby, 1982, Low dosage oral contraception in women with previous gestational diabetes, Obstetrics and Gynecology, 59, 325 Skouby, 1984, Consequences of intrauterine contraception in diabetic women, Fertility and Sterility, 42, 568, 10.1016/S0015-0282(16)48140-9 Skouby, 1985, Triphasic oral contraceptives: metabolic effects in normal women and those with previous gestational diabetes, American Journal of Obstetrics and Gynecology, 153, 495, 10.1016/0002-9378(85)90460-0 Skouby, 1985, Hormonal contraception in diabetic women: acceptability, diabetes regulation and influence on ovarian function of a nonalkylated estrogen/progestogen compound, Contraception, 32, 23, 10.1016/0010-7824(85)90113-1 Skouby, 1986, Oral contraceptives in diabetic women: metabolic effects of four compounds with different estrogen/progestogen profiles, Fertility and Sterility, 46, 858, 10.1016/S0015-0282(16)49825-0 Skouby, 1987, Oral contraception and insulin sensitivity: in vivo assessment in normal women and in subjects with previous gestational diabetes, Journal of Clinical Endocrinology and Metabolism, 64, 519, 10.1210/jcem-64-3-519 Spellacy, 1972, The effect of estrogens on carbohydrate metabolism: glucose, insulin and growth hormone studies on one hundred and seventy one women ingesting Premarin, mestranol and ethinyl estradiol for six months, American Journal of Obstetrics and Gynecology, 114, 378, 10.1016/0002-9378(72)90615-1 Spellacy, 1979, Carbohydrate metabolism prospectively studied in women using a low-estrogen oral contraceptive for six months, Contraception, 20, 137, 10.1016/0010-7824(79)90086-6 Steel, 1980, Contraception for the insulin dependent diabetic woman: the view from one clinic, Diabetes Care, 3, 557, 10.2337/diacare.3.4.557 Szabo, 1970, Glucose tolerance in gestational diabetic women during and after treatment with a combination-type oral contraceptive, New England Journal of Medicine, 282, 646, 10.1056/NEJM197003192821203 Upton, 1983, The phasic approach to oral contraception: the triphasic concept and its clinical application, International Journal of Fertility, 28, 121 Vessey, 1982, Efficacy of different contraceptive methods, Lancet, i, 841, 10.1016/S0140-6736(82)91885-2 Wallace, 1979, Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use, Lancet, ii, 111, 10.1016/S0140-6736(79)90001-1 Westrom, 1976, The risk of pelvic inflammatory disease in women using intrauterine contraceptive devices as compared to non-users, Lancet, ii, 221, 10.1016/S0140-6736(76)91025-4 Wiese, 1977, Intrauterine contraception in diabetic women, Fertility and Sterility, 28, 422, 10.1016/S0015-0282(16)42489-1 Wingrave, 1979, Oral contraceptives and diabetes mellitus, British Medical Journal, i, 23, 10.1136/bmj.1.6155.23 Zavaroni, 1987, Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance, American Journal of Medicine, 83, 609, 10.1016/0002-9343(87)90887-4